Pharma News
-
![£500,000 grant could lead to a new class of antibiotics to combat superbugs]( "£500,000 grant could lead to a new class of antibiotics to combat superbugs")
£500,000 grant could lead to a new class of antibiotics to combat superbugs
2018-11-16A new antibiotic, hailed as the “last line of defence” in the battle against drug-resistant superbugs such as MSRA and VRE, is taking the next step in development ... thanks to a UK Government grant of almost £500,000
-
![Suven Life Sciences secures product patents in Israel and Japan]( "Suven Life Sciences secures product patents in Israel and Japan")
Suven Life Sciences secures product patents in Israel and Japan
2018-11-16The granted claims of the patents include the class of selective M1 PAM and 5-HT4 compounds respectively and are being developed as ther...
-
![Nominations & applications invited for CDRI awards in drug research development]( "Nominations & applications invited for CDRI awards in drug research development")
Nominations & applications invited for CDRI awards in drug research development
2018-11-16These awards are given annually to Indian nationals below 45 years of age who are engaged in basic and applied research in the area havi...
-
![Local pharma formulators to benefit from new USFDA generic guidance: Report]( "Local pharma formulators to benefit from new USFDA generic guidance: Report")
Local pharma formulators to benefit from new USFDA generic guidance: Report
2018-11-16The regulatory clarity will benefit formulators such as Lupin (inhalation, injectable and ophthalmic), Cadila Healthcare (inhalation and...
-
![CCI blames unreasonable trade margins for high drug prices]( "CCI blames unreasonable trade margins for high drug prices")
CCI blames unreasonable trade margins for high drug prices
2018-11-16In the note, the regulator said various industry practices choke competition but do not violate the competition law.
-
![AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn]( "AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn")
AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn
2018-11-14In addition to Synagis, the deal also means that Sobi will receive 50% of all future earnings of candidate drug MEDI8897, a follow-on ca...
-
![Lannett Enters Into Agreement with Amneal for Levothyroxine]( "Lannett Enters Into Agreement with Amneal for Levothyroxine")
Lannett Enters Into Agreement with Amneal for Levothyroxine
2018-11-14Lannett will continue to distribute the two other products in its distribution agreement with JSP, Butalbital, Aspirin, Caffeine with Co...
-
![BridgeBio Pharma Enters Genetic Disease Alliance]( "BridgeBio Pharma Enters Genetic Disease Alliance")
BridgeBio Pharma Enters Genetic Disease Alliance
2018-11-14"We are excited to launch this new alliance with BridgeBio to bring new and innovative therapies to some of the most vulnerable patients...
-
![SMC endorses EUSA Pharma’s Qarziba]( "SMC endorses EUSA Pharma’s Qarziba")
SMC endorses EUSA Pharma’s Qarziba
2018-11-14Qarziba, when used in the maintenance phase of treatment for patients who did not receive prior immunotherapy, is also used to keep cond...
-
![CRISPR and MaxCyte sign licensing deal for cancer therapies]( "CRISPR and MaxCyte sign licensing deal for cancer therapies")
CRISPR and MaxCyte sign licensing deal for cancer therapies
2018-11-14MaxCyte president and CEO Doug Doerfler said: “The expansion of our relationship with CRISPR Therapeutics signifies a key milestone for ...
-
![MSD’s Keytruda approved for liver cancer]( "MSD’s Keytruda approved for liver cancer")
MSD’s Keytruda approved for liver cancer
2018-11-14The approval of Keytruda “is important, as it provides a new treatment option for patients with hepatocellular carcinoma who have been p...
-
![Preventing downtime in pharmaceuticals]( "Preventing downtime in pharmaceuticals")
Preventing downtime in pharmaceuticals
2018-11-13When considering these methods and all that IoT platforms like GE Digital’s Predix can provide, there is a plethora of efficiency raisin...
-
![The Falsified Medicines Directive]( "The Falsified Medicines Directive")
The Falsified Medicines Directive
2018-11-13To be compliant and report to the national hubs, wholesalers, distributors and logistics partners are going to have to review current pr...
-
![Catapult and MRC unite to advance human-based drug evaluation]( "Catapult and MRC unite to advance human-based drug evaluation")
Catapult and MRC unite to advance human-based drug evaluation
2018-11-13Sign up for your free email newsletter As the partnership develops it will combine the cell biology and pharmacology expertise of CDSS w...
-
![The rise of independent excipients]( "The rise of independent excipients")
The rise of independent excipients
2018-11-07The pressure to innovate faster than their competitors has drug formulators exploring new ways to optimise manufacturing processes
-
![Regulatory Pancreatic cancer treatment heads in promising direction]( "Regulatory Pancreatic cancer treatment heads in promising direction")
Regulatory Pancreatic cancer treatment heads in promising direction
2018-11-07Despite the disappointing history of drug development in pancreatic cancer, the therapeutic pipeline and clinical development is headed in a promising direction, claims GlobalData
-
![FDA approves Colorcon’s iron oxide petition to expand colour spectrum]( "FDA approves Colorcon’s iron oxide petition to expand colour spectrum")
FDA approves Colorcon’s iron oxide petition to expand colour spectrum
2018-11-07Colorcon's petition for the use of iron oxide as a colour additive for use in dietary supplement tablets and capsules has now been approved
-
![Diamond Pharma Services wins two categories at TOPRA Awards]( "Diamond Pharma Services wins two categories at TOPRA Awards")
Diamond Pharma Services wins two categories at TOPRA Awards
2018-11-07Double win in the Futures and Support categories recognises Diamond’s role supporting Kite Pharma Inc in the development of its breakthrough CAR-T cell cancer therapy
-
![Limits of drug repurposing]( "Limits of drug repurposing")
-
![Laurus Labs transfers ANDA for tenofovir disoproxil fumarate to CASI Pharma]( "Laurus Labs transfers ANDA for tenofovir disoproxil fumarate to CASI Pharma")
Laurus Labs transfers ANDA for tenofovir disoproxil fumarate to CASI Pharma
2018-11-07Laurus Labs transfers ANDA for tenofovir disoproxil fumarate to CASI Pharma
-
Pharmaceutical Industry Overview
The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.Published in: Aug. 2024
Hot News
-
Top 10 Global CDMO Rankings in 2022
-
Sanofi and Translate Bio mRNA COVID-19 vaccine candidate induced high antibody
-
Forecast of TOP 10 global best-selling drugs in 2021
-
Lilly's GLP-1 and Tirzepatide initiates phase III clinical trial
-
COVID-19 vaccine AZD1222 clinical trials resumed in the UK
-
China State Drug Administration officially approved Semaglutide for type 2 diabetes
-
Top 30 best-selling oncology drugs in the world in 2020
-
Breaking News! China's First KRAS G12D Inhibitor Approved for Clinical Use
-
Pfizer and BioNTech propose expansion of pivotal COVID-19 vaccine trial
-
AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
